FDA Approved: MONTELUKAST — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a Supplemental Application for montelukast submitted by Sandoz Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Exercise-induced Bronchoconstriction
• Seasonal Allergic Rhinitis

Drugs mentioned

• Montelukast (Montelukast)

Snippet

SUPPL AP for MONTELUKAST (MONTELUKAST)